Broncus Technologies
Cardiac Assist
Cathay Industrial Biotech
ChemoCentryx
Cylene Pharmaceuticals
Delenex Therapeutics
Devax
Enanta Pharmaceuticals
Interventional Spine
Lux Biosciences
Medimpulse Holding
MiCardia
Mpex Pharmaceuticals
mtm laboratories
Nabriva Therapeutics
Nereus Pharmaceuticals
Ophthotech
Pacira Pharmaceuticals
Paratek Pharmaceuticals
PharmaSwiss
Probiodrug
PTC Therapeutics
Recorders & Medicare Systems (ehemals Tensys Medical)
Sloning BioTechnology
Surface Logix
Symphony Evolution
Vivacta
Westmed Holding
Weitere Details zu den privaten Unternehmen finden Sie hier:
Private Unternehmen per 30.6.2010
News
Finanzberichte
Aktienkurs
 | |||
| |||
Kennzahlen
| per 31.8.2010 | CHF |
| NAV pro Aktie |
62.58 |
| Nettovermögen | 616 Mio. |
Suchen
Mitteilungen abonnieren